• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2400245 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2024-09-14 Anhui Anke Biotechnology (Group) Co Ltd view
CYSB2000354 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2020-12-18 长春生物制品研究所有限责任公司 Changchun Lnstitute of Biological Products Co Ltd In Review 2022-01-27 view
CYSB2300186 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2023-10-19 Beijing Yuance Pharmaceutical Co Ltd view
CYSB2400003 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2024-01-04 Changchun Lnstitute of Biological Products Co Ltd view
CYSB2300188 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2023-10-19 Beijing Yuance Pharmaceutical Co Ltd view
CYSB2400002 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2024-01-04 Changchun Lnstitute of Biological Products Co Ltd view
CYSB2300187 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2023-10-19 Beijing Yuance Pharmaceutical Co Ltd view
CYSB2400244 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2024-09-14 Anhui Anke Biotechnology (Group) Co Ltd view
CYSB2000356 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2020-12-18 长春生物制品研究所有限责任公司 Changchun Lnstitute of Biological Products Co Ltd In Review 2022-01-27 view
CYSB2400246 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2024-09-14 Anhui Anke Biotechnology (Group) Co Ltd view
CYSB2000355 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2020-12-18 长春生物制品研究所有限责任公司 Changchun Lnstitute of Biological Products Co Ltd In Review 2022-01-27 view
CYSB2400004 注射用人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2024-01-04 Changchun Lnstitute of Biological Products Co Ltd view
CSB01069 注射用重组人干扰Α-2B Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2001-11-12 上海万兴生物制药有限公司 Shanghai Wanxing Biological Pharmaceutical Co Ltd Certificate Issued 2002-09-18 view
X0306833 注射用重组人干扰素a2b Recombinant Human Interferon α2b Lyophilized Biological Products New Drug Application 2003-12-28 北京瑞得合通药业有限公司 Beijing Ruide Hetong Pharmaceutical Co Ltd Certificate Issued 2005-01-27 view
CSb01044 注射用重组人干扰素a2b Recombinant Human Interferon α2b Lyophilized Biological Products(2) Supplementary Application 2001-07-27 北京远策药业有限责任公司 Beijing Yuance Pharmaceutical Co Ltd Certificate Issued 2001-11-14 view
J0300686 注射用重组人干扰素α-2b Recombinant Human Interferon α2b Lyophilized Biological Products License Renew 2004-05-13 先灵葆雅(欧洲)公司 Schering-Plough Europe Certificate Issued 2005-02-02 view
X0302914 注射用重组人干扰素α-2b Recombinant Human Interferon α2b Lyophilized Biological Products New Drug Application 2003-06-12 海南通用同盟药业有限公司 Hainan General Alliance Pharmaceutical Co Ltd Certificate Issued 2004-04-23 view
CSS01002 注射用重组人干扰素α-2b(酵母) Recombinant Human Interferon α2b Lyophilized Biological Products(2) New Drug Application 2001-01-22 复旦大学上海万兴生物制药有限公司 Certificate Issued 2001-08-10 view
CYSB1600190 注射用重组人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2017-05-11 北京凯因科技股份有限公司 Beijing Kawin Technology Share-Holding Co Ltd Certificate Issued 2018-06-28 view
CYSB2000401 注射用重组人干扰素α2b Recombinant Human Interferon α2b Lyophilized Biological Products Supplementary Application 2020-12-29 北京远策药业有限责任公司 Beijing Yuance Pharmaceutical Co Ltd In Review 2022-01-27 view